Abbott Laboratories

Abbott Laboratories, a global healthcare company established in 1888 and headquartered in Abbott Park, Illinois, United States, is dedicated to providing a wide range of products and services in diagnostics, medical devices, nutrition, and pharmaceuticals across over 150 countries. The company believes in delivering exceptional healthcare experiences to patients worldwide and has made significant investments in research and development to create innovative and effective products that improve patient outcomes and quality of life.

Abbott's commitment to innovation has led to its success in emerging markets, where it has established a strong presence and customer base. The company is well-positioned to meet the growing healthcare needs of these regions, further expanding its reach and making a significant contribution to global healthcare.

Abbott is a publicly traded company listed on the New York Stock Exchange (NYSE), boasting a strong financial position, a solid balance sheet, and consistent revenue and earnings growth. Abbott is widely acknowledged as a leader in the global healthcare industry, with a reputation for stability and excellence. The company's unwavering commitment to improving the health and well-being of people worldwide through exceptional healthcare products and services has cemented its position as a trailblazer in the industry.

In 1888, physician and drug store proprietor Dr. Wallace C. Abbott began producing accurate, scientifically formulated medications with the goal of providing more effective therapies to patients and the physicians providing their care. This marked the beginning of Abbott Laboratories, a company that has since grown and innovated to serve its customers around the world. Important milestones in its history include the development of Chlorazene, Butyn, Pentothal, and the ABA-100 blood chemistry analyzer. 

In the 1950s, Abbott Laboratories began to expand its operations into foreign markets. In 1957, the company acquired Ross Laboratories, a Canadian pharmaceutical company. That same year, Abbott opened its first international production facility in Canada. In the 1960s, Abbott Laboratories developed a number of new drugs including the antibiotic Bactrim and the anticonvulsant Dilantin. In 1964, Abbott Laboratories acquired the Ross-Miles pharmaceutical company.

In the 1970s and 1980s, Abbott Laboratories continued to expand its operations and develop new products. In 1976, the company acquired the Knoll Pharmaceutical Company, giving it access to a portfolio of drugs including the anti-inflammatory Motrin and the antacid Maalox. In 1979, Abbott Laboratories launched its first diagnostic product, the T4 Thyroxine Test, which could detect low levels of the thyroid hormone in blood. In 1983, the company acquired the Miles Laboratories, giving it access to the Alka-Seltzer and One-A-Day brands.

In the 1990s and 2000s, Abbott Laboratories continued to expand its operations and develop new products. In 1991, the company acquired the International Clinical Laboratories, which gave it access to a wide range of diagnostic and medical testing services. In 1999, Abbott Laboratories acquired the Knoll Pharmaceutical Company, giving it access to a portfolio of drugs including the anti-inflammatory Motrin and the antacid Maalox. 

In 2000, Abbott Laboratories acquired the BASF Pharmaceuticals division, giving it access to a number of drugs including the antibiotic Cipro. In 2004, the company acquired the Solvay Pharmaceuticals division, giving it access to a number of drugs including the antidepressant Luvox and the antipsychotic Abilify.

In the 2010s and 2020s, Abbott Laboratories has continued to expand its operations and acquire new companies. In 2013, the company acquired the pharmaceutical division of Solvay SA, giving it access to a number of drugs including the antidepressant Luvox and the antipsychotic Abilify. In 2015, Abbott Laboratories acquired the diagnostic division of Alere, giving it access to a range of diagnostic tests for infectious diseases, cancer, and cardiovascular disease. In 2018, the company acquired the medical device maker St. Jude Medical, giving it access to a range of medical devices. In 2020, Abbott Laboratories acquired the diagnostic testing company LabCorp, giving it access to a range of tests for infectious diseases, cancer, and cardiovascular disease.

The core objective of Abbott Laboratories is to enhance people's lives by promoting their health and well-being. The company is committed to achieving this mission by providing innovative and affordable healthcare solutions that can help people live their best lives. Abbott Laboratories strives to promote diversity and inclusion in the STEM fields, with a particular focus on empowering women and underrepresented communities. The company also places a strong emphasis on supporting and motivating their employees, encouraging them to pursue their passions and goals, and fostering a culture of collaboration and excellence.

Abbott Laboratories is a global healthcare company with a clear vision of becoming a trusted leader in the industry. The company is dedicated to developing and providing innovative solutions that enhance the quality of life for individuals across the world. Abbott's focus is on delivering superior products and services that contribute to the improvement of health outcomes and promote overall wellness.

As a leader in the healthcare sector, Abbott aims to be at the forefront of the industry, leading the way with cutting-edge research and development. With an unwavering commitment to innovation, Abbott invests heavily in research and development to develop new products and services that can improve the lives of people worldwide.

Abbott's diagnostics division offers a wide range of products and services, including clinical laboratory diagnostics, point-of-care diagnostics, and molecular diagnostics. The medical devices division offers products such as heart stents, catheter-based systems, and glucose monitoring devices. Abbott's nutrition division offers products such as infant formula, pediatric nutrition, and clinical nutrition. The pharmaceuticals division offers products such as cardiovascular, generic, and specialty pharmaceuticals.